News

Takeda and Charles River in Drug Discovery Pact

Azelis Strengthens Indian Pharma Footprint

Azelis is to acquire S. Zhaveri Pharmakem, expanding its presence in India and gaining a significant footprint in the country’s fast-growing pharmaceutical market. Headquartered in Mumbai, S. Zhaveri serves both domestic and international principal suppliers to India’s pharmaceutical market.

Merck KGaA Invests in Swiss Biotech Center

Celanese Strengthens Acetyls Business

BASF and Solvay Complete PA Deal

Nouryon Buys J.M. Huber’s CMC Business

US States Sue EPA over Chemical Plant Safety

Air Liquide Talks to Messer on Assets Sale

Saipem Takes CSI’s Carbon Capture Technology

EU to Rule on Aramco-SABIC Deal by Feb. 27

Lanxess Digitizes its Global Asset Base

Catalent Appoints Ricci Whitlow as President of Clinical Supply Services

Schrödinger and Bayer to Collaborate on Acceleration of Drug Discovery

Marquis Sues Novozymes on Trade Secrets

BASF Spends in Spain and Italy

AstraZeneca Aims to be Carbon Neutral by 2025

Ergomed Acquires Ashfield Pharmacovigilance

Indorama Absorbs Huntsman EO & PO Assets

Lonza's next CEO to Come from Pharma or Biotech

Alexander Robertson Appointed as Chief Marketing Officer of ACG Group

Topsoe Wins Russian Methanol Project

Piramal Sells Healthcare Analytics to Clarivate

Sanofi Completes $2.5 Billion Synthorx Acquistion

Axens Wins Borouge 4 Contract

Lilly to Build Injectables Plant in North Carolina

Azelis Completes Megafarma Acquisition

Strategic Realignment for HSH Chemie and Ter Chemicals

ECJ Advisor Says GSK Abused Position in Payoff

Orbia Mulls Sale of Vinyls Business

Italmatch Buys ICL’s Phosphorus Process

Wuxi Biologics to Take Bayer Plant at Leverkusen

McDermott Sells Lummus to Chatterjee/Rhone

BASF Upgrades Polyacrylates at Ludwigshafen

Domo Chemicals Appoints Yves Bonte as CEO and Chairman of the Board

IMCD Buys Israeli Distributor